Contrast Enhanced Ultrasound for Radio Frequency Ablation of Canine Prostates: Initial Results

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1654-1660

  Liu, Ji Bin ^a   Merton, Daniel A ^a   Wansaicheong, Gervais ^d   Forsberg, Flemming ^a   Edmonds, Pamela R ^a   Deng, Xue Dong ^b   Luo, Yan ^c   Needleman, Laurence ^a   Halpern, Ethan ^a   Goldberg, Barry B ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

ablation; contrast media; neoplasms; prostate; ultrasonography

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; DOPPLER FLOWMETRY; FEASIBILITY STUDY; INFUSION; LINEAR REGRESSION ANALYSIS; MALE; MEASUREMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIOFREQUENCY ABLATION; RANK SUM TEST; STATISTICAL ANALYSIS; STUDENT T TEST; THERMAL INJURY; ULTRASOUND;

ANIMALS; CATHETER ABLATION; CONTRAST MEDIA; DOGS; DRUG ADMINISTRATION SCHEDULE; ENDOSONOGRAPHY; FERRIC COMPOUNDS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; IRON; MALE; MODELS, ANIMAL; OXIDES; PROSTATE; SURGERY, COMPUTER-ASSISTED; ULTRASONOGRAPHY, DOPPLER;

EID: 33748106148     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.090     Document Type: Article

References (20)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8
2. Cancer Statistics Review 1973-1992. National Institutes of Health Publication 95-2789 (1995), National Cancer Institute Division of Cancer Prevention and Control, Bethesda
3. Quinlan D.M., Partin A.W., and Walsh P.C. Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?. Urology 46 suppl (1995) 77
4. Middleton R.G., Thompson I.M., Austenfeld M.S., Cooner W.H., Correa R.J., Gibbons R.P., et al. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 154 (1995) 2144
5. Lawton C.A., Won M., Pilipich M.V., Asbell S.O., Shipley W.U., Hanks G.E., et al. Long-term treatment sequelae following external bean irradiation for adenocarcinoma of the prostate. analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21 (1991) 935
6. Gerber G.S., Thisted R.A., Scardino P.T., Frohmuller H.G., Schroder F.H., Paulson D.F., et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 276 (1996) 615
7. Trojan L., Kiknavelidze K., Knoll T., Alken P., and Michel M.S. Prostate cancer therapy. standard management, new options and experimental approaches. Anticancer Res 26 (2005) 551
8. Solbiati L., Goldberg S.N., Ierace T., Livraghi T., Meloni F., Dellanoce M., et al. Hepatic metastases. percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 205 (1997) 367
9. Boehm T., Malich A., Goldberg S.N., Hauff P., Reinhardt M., Reichenback J.R., et al. Radio-frequency ablation of VX2 rabbit tumors. assessment of completeness of treatment by using contrast-enhanced harmonic power Doppler US. Radiology 225 (2002) 815
10. Liu J.B., Goldberg B.B., Merton D.A., Rawool N.M., Needleman L., and Forsberg F. The role of contrast-enhanced sonography for radiofrequency ablation of liver tumors. J Ultrasound Med 20 (2001) 517
11. Solbiati L., Goldberg S.N., Ierace T., Dellanoce M., Livraghi T., and Gazelle G.S. Radio-frequency ablation of hepatic metastases. postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 211 (1999) 643
12. Forsberg F., Johnson D.K., Merton D.A., Liu J.B., Losco P.E., Hagen E.K., et al. Contrast enhanced transrectal sonography of a novel canine prostate cancer model. J Ultrasound Med 21 (2002) 1003
13. Hagen E.K., Forsberg F., Aksnes A.K., Merton D.A., Liu J.B., Tornes A., et al. Enhanced detection of blood flow in the normal canine prostate using an ultrasound contrast agent. Invest Radiol 35 (2000) 118
14. Adegboyega P.A., Adesokan A., Haque A.K., and Boor P.J. Sensitivity and specificity of triphenyl tetrazolium chloride in the gross diagnosis of acute myocardial infarcts. Arch Pathol Lab Med 121 (1997) 1063
15. McGahan J.P., Griffey S.M., Budenz R.W., and Brock J.M. Percutaneous ultrasound-guided radiofrequency electrocautery ablation of prostate tissue in dogs. Acad Radiol 2 (1995) 61
16. Schulman C.C., and Zlotta A.R. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia. early clinical experience. Urology 45 (1995) 28
17. Zlotta A.R., Djavan B., Matos C., Noel J.C., Peny M.O., Silverman D.E., et al. Percutaneous transperineal radiofrequency ablation of prostate tumor. safety, feasibility and pathological effects on human prostate cancer. Br J Urol 81 (1998) 265
18. Hagen E.K., Forsberg F., Liu J.B., Gomella L.G., Aksnes A.K., Merton D.A., et al. Contrast-enhanced power Doppler imaging of normal and decreased blood flow in canine prostates. Ultrasound Med Biol 27 (2001) 909
19. Forsberg F., Liu J.B., Chiou H.J., Rawool N.M., Parker L., and Goldberg B.B. Comparison of fundamental and wideband harmonic contrast imaging of liver tumors. Ultrasonics 38 (2000) 110
20. Onik G. The male lumpectomy. rationale for a cancer targeted approach for prostate cryoablation. A review. Technol Cancer Res Treat 3 (2004) 365